Persistent MRSA Bacteraemia in a Haemodialysis Patient with a Tunnelled Catheter
A 61-year-old man on maintenance haemodialysis through a tunnelled right internal jugular catheter is admitted with a 2-day history of fever (39.2 °C), rigors during dialysis and malaise. Two sets of blood cultures taken at admission grow MRSA in both bottles within 18 hours. The catheter is his only vascular access and the team is reluctant to remove it because his peripheral veins are poor. He is started on vancomycin with AUC-guided dosing; on day 5 he remains febrile, with a peak of 38.9 °C. He now reports a dull lower back pain that is worse at night. Examination shows no focal neurology, no spinal tenderness and no new murmur. Transthoracic echocardiography on day 2 was reported as normal. White cell count 13.8 × 10⁹/L, CRP 168 mg/L. He asks why he is 'still on the same antibiotic' and whether the line can stay.
1. Why is catheter removal central to management, and how would you organise it?
Read the worked answer
This is a catheter-related bloodstream infection with MRSA, and the catheter is almost certainly the source. Biofilm on the catheter lumen protects organisms from vancomycin, so medical therapy alone frequently fails.
Consequences of leaving it in: persistent bacteraemia, metastatic seeding (endocarditis, vertebral osteomyelitis, epidural abscess), septic shock, and increased mortality. Catheter salvage with antibiotic locks has been described, but it is reserved for selected, uncomplicated, non-tunnelled infections with a stable patient, a removable organism and no metastatic focus - none of which applies after 5 days of persistent fever.
Organising removal:
- Involve vascular access surgery and interventional radiology the same day; use a temporary non-tunnelled dialysis catheter (preferably with a different site) or an existing arteriovenous fistula/graft for dialysis in the interim.
- Send the catheter tip for culture and take paired peripheral and catheter blood cultures before removal if this has not already been done.
- Escalate to the dialysis unit and infection team, and document that difficulty of access is not a reason to retain an infected prosthesis.
Explain to him that removing the line is the treatment, not an obstacle to it.
2. How do you evaluate fever persisting at day 5, and what antibiotic changes are reasonable?
Read the worked answer
Persistent fever on appropriate vancomycin has a short differential: inadequately treated source (retained catheter), metastatic focus, drug fever, or a second infection.
Assessment steps:
- Check the vancomycin exposure - confirm AUC 400–600 mg·h/L with correct dosing around dialysis; under-dosing in dialysis patients is common.
- Repeat blood cultures before any change, and again 48–72 hours after catheter removal to confirm clearance.
- Transoesophageal echocardiography - transthoracic is insensitive, and MRSA bacteraemia warrants TEE.
- MRI of the whole spine for the new back pain; vertebral osteomyelitis or epidural abscess is a classic metastatic focus and would extend treatment substantially.
- Look for other foci: pacemaker, prosthetic joint, intravascular device, and inspect the exit site and tunnel.
Antibiotic decisions: if he remains bacteraemic on adequate vancomycin, switch to daptomycin 8–10 mg/kg IV after each dialysis session (monitor creatine kinase), with or without a second agent such as ceftaroline for persistent MRSA bacteraemia. Adding gentamicin is not recommended for MRSA. None of this substitutes for source control.
3. What total duration of therapy would you plan, and by what criteria would you stop?
Read the worked answer
Duration depends on the deepest focus found, and it is counted from the first documented negative blood culture, not from admission.
Scenarios:
- Uncomplicated catheter-related MRSA bacteraemia with the catheter removed, no endocarditis and no metastatic focus: at least 2 weeks is sometimes used, but 4 weeks is commonly preferred for MRSA because of relapse risk, especially in a dialysis patient.
- Native-valve endocarditis: 6 weeks of intravenous therapy.
- Vertebral osteomyelitis/discitis: 6–8 weeks (longer, up to 12 weeks, with an epidural abscess or mechanical instability); some patients need surgical decompression.
- Prosthetic material: longer, and often requires removal.
Criteria to stop and follow-up:
- Clinical resolution of fever and symptoms, negative repeat blood cultures at 48–72 hours and at the end of therapy, and radiological improvement where relevant.
- Surveillance blood cultures after completion in a dialysis patient, given relapse risk.
- Arrange a new permanent access plan (fistula or graft) before discharge, review dialysis adequacy, and give a clear safety-net plan: return urgently for fever, back pain or rigors during dialysis.